Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06883344 · ClinicalTrials.gov registry record · NA
Automated Insulin for Management of Intrapartum Glycemia
A NA study of Pregnancy and Type 1 Diabetes (T1D), sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06883344: Recruiting NA study of Pregnancy and Type 1 Diabetes (T1D), sponsored by University of California, San Francisco.
NCT06883344 is a NA study of Pregnancy and Type 1 Diabetes (T1D) that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 150 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06883344, a NA study of Pregnancy and Type 1 Diabetes (T1D), is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is learn if automated insulin delivery (AID) systems can be used for glucose management during labor/delivery for pregnant people with type 1 diabetes (T1D). The main questions this study aims to answer are * What are the neonatal glycemic outcomes with use of AID systems during labor/delivery? * Do patients report higher birth satisfaction with use of AID systems during labor/delivery? * Are glycemic parameters like time-in-range (TIR) better with use of AID systems during labor/delivery? Researchers will compare AID systems to intravenous (IV) insulin (the current standard of care for glucose management during labor/delivery) by randomly assigning participants to one or the other.
Primary Outcome
A primary clinical goal of intrapartum glycemic management is to minimize the likelihood of low neonatal glucose values (hypoglycemia).
Conditions Studied
Interventions
- DEVICE Automated insulin delivery (AID) system
- OTHER Intravenous (IV) insulin
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-12-05 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06883344 shows while recruiting
NCT06883344 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (83% lower).
The record links to 3 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Automated insulin delivery (AID) system is the first listed.
NCT06883344 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06883344 about?
NCT06883344 is a clinical study titled "Automated Insulin for Management of Intrapartum Glycemia". The goal of this clinical trial is learn if automated insulin delivery (AID) systems can be used for glucose management during labor/delivery for pregnant people with type 1 diabetes (T1D). The main questions this study aims to answer are * What are the neonatal glycemic outcomes with use of AID sy...
What is the current status of trial NCT06883344?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-12-05. Estimated completion is 2026-12-31.
What conditions does trial NCT06883344 study?
This clinical trial studies the following conditions: Pregnancy, Type 1 Diabetes (T1D), Pre-Gestational Diabetes.
What interventions are being tested in trial NCT06883344?
The interventions under investigation include: Automated insulin delivery (AID) system (DEVICE), Intravenous (IV) insulin (OTHER).
Who is sponsoring clinical trial NCT06883344?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06883344 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06883344's enrollment target sits among peer trials
150 96th of 191 higher than 93 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Feasibility of an ADAPTive Intervention to Improve Food Security and Maternal-Child Health
RECRUITING · NA
-
Enhancing Care & Outcomes for Patients During the First Postpartum Year
RECRUITING · NA
-
Mitigating Response to Stressors in Pregnant Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI